Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables - Poll - MDSpire

Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables

  • By

  • Yiwei Zhao

  • Chutong Zhao

  • Yujie Liu

  • Yuan Wang

  • Yunyan Zhang

  • Sijia Liu

  • March 7, 2026

  • 0 min

Share

Original Source(s)

Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables

  • by Yiwei Zhao, Chutong Zhao, Yujie Liu, Yuan Wang, Yunyan Zhang, Sijia Liu

  • March 7, 2026

Related Content

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

A volume-controlled, anatomy-driven autoplanning strategy for whole-pelvic volumetric modulated arc therapy

Dose Estimation Using 3D Transformer Models in High-Dose-Rate Brachytherapy for Cervical Cancer